Playing chess or other board games slows cognitive decline and improves quality of life in older patients, results of a new systematic review suggest.
… After searching the published literature, Pozzi and his colleagues selected 15 studies for the review. The studies assessed the impact of board games on older individuals at risk of, or with cognitive impairment, or those with mild cognitive impairment (MCI) at any age. [Read more…] about Study: Playing board games like Chess, Mahjong, Go, helps slow cognitive decline as we age (but with clear differences in neurobiology and improved function)
How AI, Digital Screening Tools Can Help Flag Early Cognitive Decline (Health IT Analytics):
Early diagnosis of Alzheimer’s and other dementias remains at the forefront of efforts to minimize the impact of these neurodegenerative diseases. But challenges such as increased life expectancy and the risks of aging, along with complexities in diagnosis and treatment resulting from mixed brain pathologies, make early detection difficult … A new pilot program at Indiana University School of Medicine and Indiana University Health, in collaboration with the Davos Alzheimer’s Collaborative (DAC), seeks to tackle these issues using digital screening tools. [Read more…] about Pilot program by IU and Davos Alzheimer’s Collaborative to test AI-powered cognitive screening at scale
Akili Interactive is the latest company to go public via SPAC deal (Boston Business Journal):
Boston’s Akili Interactive Labs Inc. is the latest Massachusetts-based company to go public after completing a reverse merger — in a year of market turmoil that saw few local firms passing the threshold between private and public status.
Shares of Akili started trading on Monday on the Nasdaq Capital Market under the new ticker symbol “AKLI” after the company completed its previously announced reverse merger with Social Capital Suvretta Holdings Corp. I (Nasdaq: DNAA), a special purpose acquisition company, or SPAC. [Read more…] about Digital therapeutics pioneer Akili Interactive Labs goes public, raising $150M+; trades down 49% first day
Mayo Clinic scientists have developed a computational model that predicts brain age using a large collection of neuroimaging data obtained using FDG-PET (fluorodeoxyglucose positron emission tomography) and structural MRI (magnetic resonance imaging). The deep learning-based model tests the relationship between brain age gaps in various forms of dementia, including mild cognitive impairment (MCI), Alzheimer’s disease (AD), frontotemporal dementia (FTD), and Lewy body dementia (LBD), as well as in normal brains.
On one of our “walk and talks” around the lush trails of Rock Creek Park in DC surrounded by bikers, runners, cars and the occasional deer, Wendy and Lisa talked about aging. Wendy’s mother, who had her children in her early 20s, was still joining the family’s grueling summer hikes with her children and nine grandchildren well into her 60s. Wendy mused about how much older she would be when their kids could have their own kids. It dawned on her that her health was not just a here and now issue, but an investment in that future. We agreed to help each other cultivate the habits and make time to build strength as well as reserves, both physical and mental, for the long-term. Their goal: to enjoy being active in their 40s and 50s while also laying the groundwork to continue being active into their 60s, 70s, and beyond. [Read more…] about New book provides practical guidance for women (and men) to rebalance our lifestyles and build Cognitive Reserve
Geisinger and Eisai Inc. today announced a collaborative effort to study the potential effectiveness of an artificial intelligence (AI) tool in the detection of cognitive impairment that could identify dementias, including Alzheimer’s disease (AD). If effective, the AI tool could potentially be developed to support the early detection and staging of cognitive impairment and dementia, leading to appropriate additional testing for the clinical, biological diagnosis and treatment of dementias such as AD. [Read more…] about Geisinger and Eisai to test real-world validity of AI-powered Passive Digital Marker (PDM) in detecting early cognitive impairment and dementia